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Abstract: A modified mathematical model describing the human immunodeficiency virus (HIV)
pathogenesis with cytotoxic T-lymphocytes (CTL) and infected cells in eclipse phase is presented and
studied in this paper. The model under consideration also includes a saturated rate describing viral
infection. First, the positivity and boundedness of solutions for nonnegative initial data are proved.
Next, the global stability of the disease free steady state and the endemic steady states are established
depending on the basic reproduction number R0 and the CTL immune response reproduction number
RCTL. Moreover, numerical simulations are performed in order to show the numerical stability for
each steady state and to support our theoretical findings. Our model based findings suggest that
system immunity represented by CTL may control viral replication and reduce the infection.
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1. Introduction
Human immunodeficiency virus (HIV) is known as a pathogen causing the acquired
immunodeficiency syndrome (AIDS), which is the end-stage of the infection. After that, the immune
system fails to play its life-sustaining role [1,2]. Indeed, it is well known that the cellular immune
responses play an indispensable role during the HIV viral infection, especially in people known as
elite controllers who are infected by HIV but maintain a normal CD4 count for many years and remain
asymptomatic or have a very delayed disease progression over the course of their HIV infection [3,4].
The basic viral infection model with CTLs immune was first studied in [5] and its global stability
was studied in [6,7]. A prevailing theory suggests that CTL cells are responsible for the sudden decrease
HIV virus load and the subsequent quasi-steady state level of the viral load after a sharp increase
during the primary infection phase [8–11]. In [12], the authors consider the interaction between CTL,
viruses and macrophages and study the global stability in a model with a mass action infection term.
With a saturated infection term, the same mathematical question was tackled in [13] with a model
consisting of four ordinary differential equations with a Beddington–DeAngelis infection term.
More recently, the model describing the interaction between the HIV viruses, CD4+ T cells,
infected cells with a standard incidence rate function describing saturated viral infection is formulated
and studied in [14]. The authors study the local and global stability of the endemic states and illustrate
that their model can fit well with some clinical HIV infection data sets. In this paper, we extend
their work by incorporating the cytotoxic T lymphocytes (CTL) immune response. The dynamics
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of HIV infection with CTL response that we consider is given by the following nonlinear system of
differential equations: 
x˙ = λ− d1x− k1xvx + v ,
s˙ =
k1xv
x + v
− d2s− k2s,
y˙ = k2s− d3y− pyz,
v˙ = ay− d4v,
z˙ = cyz− bz,
(1)
with the initial conditions x(0) = x0, s(0) = s0, y(0) = y0, v(0) = v0 and z(0) = z0.
In this model, x, y, s, v and z denote the concentration of uninfected cells, infected cells, exposed
cells, free virus and CTL cells, respectively. Susceptible host cells CD4+ T cells are produced at a rate
λ, die at a rate d1x and become infected by virus at a rate
k1xv
x + v
. Exposed cells die at a rate d2s and
become infected at a rate of k2s. Infected cells increase at rate k2s and die at rate d3y and are killed
by the CTL response at a rate pyz. Free virus is produced by infected cells at a rate ay and decays at
a rate d4v. Finally, CTLs expand in response to viral antigen derived from infected cells at a rate cyz
and decay in the absence of antigenic stimulation at a rate bz. Note that this model (1) employs the
more realistic standard incidence rate function
k1xv
x + v
as in [14,15], which better describes the rate of
viral infection. The schematic representing the viral dynamics of the problem under consideration is
illustrated in Figure 1.
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Figure 1. Schematic of the model under consideration.
The rest of the paper is organized as follows. In Section 2, we study the positivity and boundedness
of solutions. We present the steady states and give a local stability result in Section 3. Section 4
is dedicated to the global stability results. Numerical simulations are performed in Section 5 and
we conclude the paper in the last section.
2. Mathematical Analysis of the HIV Model
2.1. Existence and Local Stability
For the problems deal with cell population evolution, the cell densities should remain non-negative
and bounded. In this section, we will establish the positivity and boundedness of solutions of the
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model (1). First of all, for biological reasons, the parameters x0, s0, y0, v0 and z0 must be larger than or
equal to 0. Hence, we have the following result:
Proposition 1. For any non-negative initial conditions (x0, s0, y0, v0, z0), system (1) has a unique solution.
Moreover, this solution is non-negative and bounded for all t ≥ 0.
Proof. The proof is given in Appendix A.
Moreover, system (1) has an infection-free equilibrium E f = (
λ
d1
, 0, 0, 0, 0), corresponding to
the maximal level of healthy CD4+ T-cells. The basic reproduction number of our problem is given
as follows:
R0 = k1
k2
d2 + k2
a
d3
1
d4
, (2)
where
k2
d2 + k2
is the proportion of exposed cells to become productively infected cells,
a
d3
is the
number of free virus production by an infected cell and
1
d4
is the average life of virus. From a biological
point of view, R0 stands for the average number of secondary infections generated by one infected cell
when all cells are susceptibles. Depending on the value of this basic reproduction number R0; in other
words, depending on these three biological proportions, we will study the stability of the free-endemic
and the endemic equilibria.
In addition to the disease free equilibrium, system (1) has three endemic equilibria. The first of
them is E1 = (x1, s1, y1, v1, z1), where
x1 =
λ
d1 + k1(1− 1R0 )
,
s1 =
k1λR0(1− 1R0 )
(d2 + k2)(d1 + k1(1− 1R0 ))((1− 1R0 )R0 + 1)
,
y1 =
d4λR0(1− 1R0 )
ad1 + ak1(1− 1R0 )
,
v1 =
λR0(1− 1R0 )
d1 + k1(1− 1R0 )
,
z1 = 0.
The second endemic steady state is E2 = (x2, s2, y2, v2, z2), where
x2 =
−abd1 − abk1 + λcd4 +
√
A
2cd1d4
,
s2 =
d3R0
k2
b(−abd1 − abk1 + λcd4 +
√
A)
c(abd1 − abk1 + λcd4 +
√
A)
,
y2 =
b
c
,
v2 =
ba
cd4
,
z2 =
d3((R0 − 1)(−ak1b + λcd4 +
√
A)− abd1(R0 + 1))
p(abd1 − ak1b + λcd4 +
√
A)
.
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The third endemic steady state is E3 = (x3, y3, v3, z3), where
x3 = − abd1 + abk1 − λcd4 +
√
A
2cd1d4
,
s3 =
k1x3v3
(k2 + d2)(x3 + v3)
,
y3 =
b
c
,
v3 =
ba
cd4
,
z3 =
k2s3 − d3y3
py3
,
with A = (abk1 − λcd4)2 + a2b2d21 + 2a2b2d1k1 + 2λabcd1d4.
The last endemic steady-state E3 will not be taken under consideration since x3 < 0, which is
not possible biologically. On the other hand, from the components of E1, it is clear that, when R0 > 1,
this endemic point exists. In what follows, we will make use of the following CTL immune response
reproduction number RCTL to classify the model system dynamics
RCTL =
cy1
b
=
cd4λR0(1− 1R0 )
abd1 + abk1(1− 1R0 )
,
depending on the value of this CTL immune reproduction number RCTL; in other words, depending
on R0 and the parameters describing the effectiveness of CTL like c and b, we will study the stability
of the endemic equilibria.
First, observe that the second endemic state E2 = (x2, y2, v2, z2) exists when RCTL > 1.
This endemic state is also called an interior equilibrium.
We explain the existence of this endemic equilibrium E2 as follows. We recall first that, in this
state, both of the free viruses and CTL cells are present. Assume that R0 > 1, in the total absence
of CTL immune response, the infected cell load per unit time is
d4λR0(1− 1R0 )
ad1+ak1(1− 1R0 )
. Via the five equations
of model (1), CTL cells reproduced due to infected cells stimulating per unit time is
cd4λR0(1− 1R0 )
ad1+ak1(1− 1R0 )
= cy1.
The CTL load during the lifespan of a CTL cell is
cd4λR0(1− 1R0 )
abd1+abk1(1− 1R0 )
= RCTL. If
cd4λR0(1− 1R0 )
abd1+abk1(1− 1R0 )
> 1, we will
have the existence of the endemic equilibrium E2.
The local stability result of the disease-free equilibrium is given as follows.
Proposition 2. The disease-free equilibrium, E f , is locally asymptotically stable for R0 < 1.
Proof. The proof is given in Appendix A.
The local stability of the other steady states is quite similar to the first one. Hence, the rest of the
work will be devoted only to the global stability analysis of the problem under consideration.
2.2. Global Stability Results
This subsection deals with the global stability analysis of the disease-free and the endemic
equilibria. Our approach involves the construction of appropriate Lyapunov functions. First, we have
the following global stability result of the disease-free equilibrium.
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Proposition 3. If R0 ≤ 1, then the endemic point E f is globally stable.
Proof. The proof is given in Appendix B.
For the global stability result of the endemic equilibrium E1, we have the following.
Proposition 4. If R0 ≥ 1 and RCTL ≤ 1, then the endemic point E1 is globally stable.
Proof. The proof is given in Appendix B.
Finally, the global stability result concerning the last endemic point E2 is given as follows.
Proposition 5. If R0 ≥ 1 and RCTL ≥ 1, then the endemic point E2 is globally stable.
Proof. The proof is given in Appendix B.
3. Numerical Results and Simulations
In order to perform the numerical simulations, system (1.1) will be solved numerically using
the fourth order Runge–Kutta iterative scheme. The parameter values or ranges used are presented
in Table 1.
Table 1. Parameters, their symbols and default values used in the suggested HIV model.
Parameters Meaning Value References
λ Source rate of CD4+ T cells [0, 10] [16]
k1 Average of infection [2.5× 10−4, 0.5] [14]
d1 Decay rate of healthy cells 0.0139 [14]
d2 Death rate of exposed CD4+ T cells 0.0495 [14]
k2 The rate that exposed become infected CD4+ T cells 1.1 [14]
d3 Death rate of infected CD4+ T cells, not by CTL killing 0.5776 [14]
a The rate of production the virus by infected CD4+ T cells [2, 1250] [14]
d4 Clearance rate of virus [0.3466, 2.4] [14]
p Clearance rate of infection 0.0024 [17]
c Activation rate CTL cells 0.15 [17]
b Death rate of CTL cells 0.5 [17]
Figure 2 shows the behavior of infection during the first 60 days. For the parameters used in
this figure, the basic reproduction number is R0 = 0.2209 < 1; we clearly see that the solutions of the
system converge to the disease-free equilibrium point E f = (827.22, 0, 0, 0, 0). This numerical result is
consistent with the theoretical result concerning the stability of E f . In addition, the plots showing the
stability of this disease-free point in phase plane are given in Figure 3.
Figure 4 shows the behavior of the infection for the first sixty days. The chosen parameters
in this figure ensure that the basic reproduction number is greater than unity (R0 = 11.049 > 1)
and the immune response reproduction number is less than unity (RCTL = 3.596× 10−1 < 1). It is
clearly seen that, in this case, all the solutions converge towards the CTL-free endemic equilibrium
E1 = (19.96, 5.98× 10−1, 1.14, 199.78, 0) that agrees with our theoretical finding concerning the stability
of E1. Moreover, the plots showing the stability of this CTL-free endemic point in phase plane are
given in Figure 5.
Finally, Figure 6 illustrates the disease dynamics when both the basic reproduction number and
the immune response reproduction number are greater than unity. Indeed, for the chosen parameters in
this figure, we have R0 = 11.049 > 1 and RCTL = 4.13 > 1. It can be seen that the infection persists and
the convergence towards the infection steady state E3 = (285.12, 6.55, 3.33, 555.55, 660.86) is observed.
This numerical result is in good agreement with the theoretical result concerning the stability of the
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last endemic equilibrium. The plots showing the stability of this final endemic point in phase plane
are given in Figure 7. In these two last figures, we clearly observe the importance of CTL immune
response in maximizing the healthy cells and reducing the viral load. It is also noteworthy that the
CTLs do not vanish in this last case, which means that CTL cells will be always present when the
infection becomes chronic.
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Figure 2. The behavior of the infection dynamics for λ = 10, d1 = 0.0139, k1 = 0.04, d2 = 0.0495,
k2 = 1.1, d3 = 0.5776, a = 2, d4 = 0.6, p = 0.0024, c = 0.15, b = 0.5. For the parameters used in this
figure, the basic reproduction number is R0 = 0.2209 < 1. Solutions of the system converge to the
disease-free equilibrium point E f = (827.22, 0, 0, 0, 0).
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Figure 3. Selective phase portraits to illustrate the solution behavior of the infection dynamics when λ = 10,
d1 = 0.0139, k1 = 0.04, d2 = 0.0495, k2 = 1.1, d3 = 0.5776, a = 2, d4 = 0.6, p = 0.0024, c = 0.15, b = 0.5.
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Figure 4. The behavior of the infection dynamics for λ = 1, d1 = 0.0139, k1 = 0.04, d2 = 0.0495,
k2 = 1.1, d3 = 0.5776, a = 100, d4 = 0.6, p = 0.0024, c = 0.15, b = 0.5. For the parameters used in
this figure, the basic reproduction number is 11.049 > 1. The immune response reproduction number
RCTL = 3.596× 10−1 < 1. In this case, all the solutions converge towards the endemic equilibrium
E1 = (19.96, 5.98× 10−1, 1.14, 199.78, 0).
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Figure 5. Selective phase portraits to illustrate the solution behavior of the infection dynamics when
λ = 1, d1 = 0.0139, k1 = 0.04, d2 = 0.0495, k2 = 1.1, d3 = 0.5776, a = 100, d4 = 0.6, p = 0.0024,
c = 0.15, b = 0.5.
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Figure 6. The behavior of the infection dynamics for λ = 10, d1 = 0.0139, k1 = 0.04, d2 = 0.0495,
k2 = 1.1, d3 = 0.5776, a = 100, d4 = 0.6, p = 0.0024, c = 0.15, b = 0.5. For the chosen parameters in
this figure, we have R0 = 11.049 > 1 and RCTL = 4.13 > 1. Solutions tending to the infection steady
state E3 = (285.12, 6.55, 3.33, 555.55, 660.86) are observed.
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Figure 7. Selective phase portraits to illustrate the solution behavior of the infection dynamics when
λ = 10, d1 = 0.0139, k1 = 0.04, d2 = 0.0495, k2 = 1.1, d3 = 0.5776, a = 100, d4 = 0.6, p = 0.0024,
c = 0.15, b = 0.5.
4. Discussion
The HIV dynamics involving the density uninfected cells, the density of the infected cells,
the density of HIV virus and the amount of CTL cells have been widely studied by means of a
different mathematical model starting from the work in 1996 by Nowak and Bangham [5] and two
years later in 1998 by [18]. Later, many mathematical approaches were developed in order to better
understand the complex dynamics of the fatal HIV disease.
Recently, in 2015, Conway and Perelson [19] studied the same issue by incorporating the treatment
into the HIV model. Motivated by all those previous works treating the dynamics of HIV along with
the CTL immune response, we have incorporated the CTL effect to a model suggested recently in
2015 by Sun et al. [14], in which the authors studied HIV dynamics by incorporating into the model
the treatment and a more realistic incidence functional that describes the infection rate taking into
account the crowd of the free viruses near the uninfected cells. In the latter work, the uninfected cells
need time to become infected after HIV virus contact. Indeed, there exists an eclipse phase that is
needed for the exposed CD4+ T cells to become infected (see Figure 1). In this paper, we have taken
into account this phase and we have added the CTL immune response to the model.
In this paper, we have established the well-posedness of the suggested model that ensures that all
the solutions exist and are bounded. This agrees with the biological reality that the total cell amounts
of these populations are bounded. Moreover, three steady states of the problem are found and their
local and global stability results are determined depending on the basic reproduction number R0 and
the CTL immune response reproduction number RCTL.
We have also presented some numerical results that confirm our theoretical findings. In addition,
several plots of the solutions in phase diagrams have been drawn in order to illustrate the stability
of the three steady states.
The model dynamics indicate that the immune response represented by the cytotoxic T
lymphocytes is efficient in controlling viral replication. Indeed, our numerical results show that,
in the endemic case (see Figure 6), the CTL immune response plays an essential role in maximizing
the effect of the uninfected CD4+ T cells, minimizing the amount of the infected cells and reducing
the HIV viral load.
5. Conclusions
In this paper, we have studied the model of the HIV dynamics in the presence of the immune
response, which is represented by the cytotoxic T lymphocytes (CTL) cells. The model describes
the interaction between the healthy cells, the infected cells in eclipse phase, the productively infected
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cells and the immune cells. The model includes also a saturated rates in order to better describe
the viral infection. The positiveness and the boundedness of solutions are established. In addition,
we have studied the stability of both disease-free equilibrium and endemic equilibria. The disease free
steady state is locally and globally asymptotically stable when the basic reproduction number is less
than unity (R0 < 1). The existence of two other infection steady states when R0 > 1 is established.
The global stability of these endemic steady states depends on the basic reproduction number R0 and
the CTL immune response reproduction number RCTL. Numerical simulations are performed in order
to show the behavior of infection during the days of observation. The theoretical and the numerical
results are in good agreement. In addition, our model based results suggest that the system immunity
represented by CTL can control viral replication and reduce the infection under appropriate conditions.
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Appendix A. Existence and Local Stability Results Proof
The proof of the existence result (Proposition 1) is as follows. First, by the classical differential
equations theory, we can confirm that system (1) has a unique local solution (x(t), s(t), y(t), v(t), z(t))
in [0, tm).
First, the solution x(t) is strictly positive for all t ∈ [0, tm). Indeed, assume the contrary, and
let t1 > 0 be the first time such that x(t1) = 0 and x˙(t1) ≤ 0. From the first equation of system (1),
we have x(t1) = λ > 0, which presents a contradiction. Therefore, x(t) > 0 for all t ∈ [0, tm). We also
have the following:
s˙|s=0 = k1xvx + v ≥ 0,
y˙|y=0 = k2s ≥ 0,
v˙|v=0 = ay ≥ 0,
and
z˙|z=0 = 0 ≥ 0.
This shows that s(t) ≥ 0, y(t) ≥ 0, v(t) ≥ 0 and z(t) ≥ 0 for all t ∈ [0, tm). On the other hand,
for the boundedness of the solutions, assume first that
X = x + s + y;
then, we will have
X˙ = λ− d1x− d2s− d3y− pyz,
≤ λ− δX,
where δ = min(d1, d2, d3). Therefore,
X(t) ≤ X(0)e−δt + λ
δ
(1− e−δt)
≤ X(0)e−δt + λ
δ
.
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By the same reasoning, concerning the fourth equation, we will have
v(t) ≤ v(0) + a
d4
‖y‖∞.
For the last equation, we will have
z˙(t) + bz(t) = cy(t)z(t)
=
c
p
(λ− (x˙(t) + d1x)− (s˙(t) + (d2 + k2)s)− (y˙(t) + d3y)) ,
from which, we will have
z(t) =
(
z(0) +
c
p
(x(0) + s(0) + y(0)− λ
b
)
)
e−bt
+
c
p
(
λ
b
+
∫ t
0
((b− d1)x + (b− (d2 + k2)s) + (b− d3)y)eb(ξ−t)dξ − x− s− y
)
≤
(
z(0) +
c
p
(x(0) + s(0) + y(0))
)
+
c
p
(
λ
b
+
1
b
max(0; b− d1))‖x‖∞
+ max(0; b− (d2 + k2))‖s‖∞ + max(0; b− d3)‖y‖∞
)
,
this proves that the solutions x(t), s(t), y(t), v(t) and z(t) are bounded. Hence, every local solution
can be prolonged up to any time tm > 0, which means that the solution exists globally.
For the local stability result (Proposition 2), the proof is stated as follows.
At the disease-free equilibrium, E f , the Jacobian matrix is given as follows:
JE f =

−d1 0 0 −k1 0
0 −k2 − d2 0 k1 0
0 k2 −d3 0 0
0 0 a −d4 0
0 0 0 0 −b
 . (A1)
The characteristic polynomial of JE f is
PE f (λ) = −λ5 + (−d1 − d4 − d3 − k2 − d2)λ4
+ (−d1(d4 + d3 + k2 + d2)− d4d3 − d4k2 − d4d2 − d3k2 − d3d2)λ3
+ (−d1(d4d3 + d4k2 + d4d2 + d3k2 + d3d2)− d4d3k2 − d4d3d2 + ak2k1)λ2
− d1(d4d3k2 + d4d3d2 − ak2k1)λ.
Therefore,
PE f (λ) = (λ+ d1)(λ+ b)(λ
3 + (d4 + d3 + k2 + d2)
λ2 + (d4d3 + d4k2 + d4d2 + d3k2 + d3d2)λ+ d4d3k2 + d4d3d2 − ak2k1),
and the two obvious first eigenvalues of the matrix JE f are−b and−d1, which are non-positive. Denoting
a1 = d4 + d3 + k2 + d2,
a2 = d4d3 + d4k2 + d4d2 + d3k2 + d3d2,
a3 = d4d3k2 + d4d3d2 − ak2k1,
(A2)
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it is easy to check that we have always a1 > 0, a2 > 0 and a1a2 − a3 > 0. In addition, it is easy
to see that a3 > 0 when R0 < 1. From the Routh–Hurwitz criterion, it follows that E f is locally
asymptotically stable.
Appendix B. Global Stability Result Proof
The global stability proof of the endemic point E f (Proposition 3) is given as follows. Consider
the following Lyapunov function:
L(x, y, s, v, z) = s + d2 + k2
k2
y +
d3(d2 + k2)
ak2
v +
p
c
d2 + k2
k2
z.
The time derivative is given by:
L˙(x, y, s, v, z) = s˙ + d2 + k2
k2
y˙ +
d3(d2 + k2)
ak2
v˙ +
p
c
d2 + k2
k2
z˙.
L˙(x, y, s, v, z) = k1xv
x + v
− (d2 + k2)s + d2 + k2k2 (k2s− d3y)−
d2 + k2
k2
pyz
+
d3(d2 + k2)
ak2
(ay− d4v) + pc
d2 + k2
k2
(cyz− bz)
L˙(x, y, s, v, z) = k1xv
x + v
− d3d4(d2 + k2)
ak2
v− bp
c
d2 + k2
k2
z
L˙(x, y, s, v, z) ≤ k1v− d3d4(d2 + k2)ak2 v
≤ d3d4(d2 + k2)
ak2
(R0 − 1) v.
If R0 < 1, then L˙ ≤ 0. Moreover, L˙ ≤ 0 when v = 0. The largest compact invariant is
E = {(x, y, s, v, z) ∈ R+∗ |v = 0},
according to LaSalle’s invariance principle, lim+∞ v(t) = 0, the limit system of equations is
x˙ = λ− d1x,
y˙ = −d2s− k2s,
s˙ = k2s− d3y− pyz,
z˙ = byz− cz.
We define another Lyapunov function and for implicity, using the same notation,
L(x, s, y, z) = 1
x0
(
x− x0 − x0 ln xx0
)
+ s +
d2 + k2
k2
y +
p
c
d2 + k2
k2
z.
Since x0 = λd1 , then
L˙(x, s, y, z) = d1
(
2− x
x0
− x0
x
)
− d3(d2 + k2)
k2
s− pb
c
z,
since the arithmetic mean is greater than or equal to the geometric mean, it follows that
2− x
x0
− x0
x
≤ 0;
therefore, L˙ ≤ 0 and the equality holds if x = x0 and s = y = z = 0, which completes the proof.
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The global stability proof of the endemic point E1 (Proposition 4) is given as follows. We employ
the following Lyapunov function:
L(x, y, s, v, z) = x− x1 −
∫ x
x1
(d2 + k2)s1
k1uv1
u + v1
du + s− s1 − s1 ln ss1
+
d2 + k2
k2
(y− y1 − y1 ln yy1 ) +
d3(d2 + k2)
ak2
(v− v1 − v1 ln vv1 )
+
p
c
d2 + k2
k2
z.
We have
L˙(x, y, s, v, z) = x˙− (d2 + k2)s1 x + v1k1xv1 x˙ + s˙−
s1
s
s˙ +
d2 + k2
k2
(y˙− y1
y
y˙)
+
d3(d2 + k2)
ak2
(v˙− v1
v
v˙) +
p
c
d2 + k2
k2
z˙.
On the other hand, we have
λ = d1x1 + (d2 + k2)s1,
k1x1v1
x1 + v1
= (d2 + k2)s1,
s1
v1
=
d3d4
ak2
,
y1
v1
=
d4
a
,
s1
y1
=
d3
k2
.
Hence,
L˙(x, s, y, v, z) =
(
λ− d1x− k1xvx + v
)(
1− (d2 + k2)s1 x + v1k1xv1
)
+
k1xv
x + v
− (d2 + k2)s− s1s
(
k1xv
x + v
− (d2 + k2)s
)
+
d2 + k2
k2
(k2s− d3y− pyz)− d2 + k2k2
y1
y
(k2s− d3y− pyz)
+
d3(d2 + k2)
ak2
(ay− d4v)− d3(d2 + k2)ak2
v1
v
(ay− d4v)
+
p
c
d2 + k2
k2
(cyz− bz),
and
L˙(x, s, y, v, z) =λ− d1x− (d2 + k2)s1 x + v1k1xv1
(
λ− d1x− k1xvx + v
)
− s1
s
(
k1xv
x + v
)
+ (d2 + k2)s1 +
d2 + k2
k2
py1z
+
(d2 + k2)d3
k2
y1 − (d2 + k2)s y1y −
d3d4(d2 + k2)
ak2
v
+
d3d4(d2 + k2)
ak2
v1 − d3(d2 + k2)k2
v1y
v
− d2 + k2
k2
bp
c
z.
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Since
λ− d1x = d1x1 + (d2 + k2)s1 − d1x,
λ− d1x− (d2 + k2)s1 x + v1k1xv1
(
λ− d1x− k1xvx + v
)
= d1x1
(
1− x
x1
− x1
x
x + v1
x1 + v1
+
x + v1
x1 + v1
)
+(d2 + k2)s1
(
1− x1
x
x + v1
x1 + v1
+
v
v1
x + v1
x + v
)
,
− s1
s
(
k1xv
x + v
)
+ (d2 + k2)s1 = − s1s
xv
x1v1
x1 + v1
x + v
(d2 + k2)s1 + (d2 + k2)s1,
we have
L˙ = d1x1
(
1− x
x1
− x1
x
x + v1
x1 + v1
+
x + v1
x1 + v1
)
+ (d2 + k2)s1
(
1− x1
x
x + v1
x1 + v1
+
v
v1
x + v1
x + v
)
+ (d2 + k2)s1
(
1− s1
s
xv
x1v1
x1 + v1
x + v
)
+ (d2 + k2)s1
(
1− sy1
s1y
− v
v1
)
+ (d2 + k2)s1
(
1− v1y
y1v
)
+ pz
d2 + k2
k2
(y1 − bc ).
Therefore,
L˙ = − d1v1
x(x1 + v1)
(x− x1)2
+ (d2 + k2)s1
(
−1− v
v1
+
v
v1
x + v1
x + v
+
x + v
x + v1
)
+ (d2 + k2)s1
(
5− x1
x
x + v1
x1 + v1
− s1
s
xv
x1v1
x1 + v1
x + v
− sy1
s1y
− yv1
y1v
− x + v
x + v1
)
+ pz
d2 + k2
k2
(y1 − bc ),
which implies that
L˙ = − d1v1
x(x1 + v1)
(x− x1)2
− (d2 + k2)s1
(
x(v− v1)2
v1(x + v1)(x + v)
)
+ (d2 + k2)s1
(
5− x1
x
x + v1
x1 + v1
− s1
s
xv
x1v1
x1 + v1
x + v
− sy1
s1y
− yv1
y1v
− x + v
x + v1
)
+ pz
d2 + k2
k2
(y1 − bc ),
since the arithmetic mean is greater than or equal to the geometric mean, it follows that
5− x1
x
x + v1
x1 + v1
− s1
s
xv
x1v1
x1 + v1
x + v
− sy1
s1y
− yv1
y1v
− x + v
x + v1
≤ 0.
In addition, when RCTL < 1, we will have y1 − bc ≤ 0, which means that L˙ ≤ 0, and the equality
hods when x = x1, y = y1, s = s1 and v = v1. By the LaSalle invariance principle, the endemic point
E1 is globally stable when R0 > 1.
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Finally, the global stability proof of the endemic point E2 (Proposition 5) is given as follows.
We employ the following Lyapunov function:
L(x, s, y, v, z) =x− x2 −
∫ x
x2
(d2 + k2)s2
k1uv2
u + v2
du + s− s2 − s2 ln ss2
+
d2 + k2
k2
(y− y2 − y2 ln yy2 ) +
d3(d2 + k2) + (d2 + k2)pz2
ak2
× (v− v2 − v2 ln vv2 ) +
p
c
d2 + k2
k2
(z− z2 − z2 ln zz2 ).
We have
L˙(x, y, s, v, z) =x˙− (d2 + k2)s2 x + v2k1xv2 x˙ + s˙−
s2
s
s˙ +
d2 + k2
k2
(y˙− y2
y
y˙)
+
d3(d2 + k2) + (d2 + k2)pz2
ak2
(v˙− v2
v
v˙) +
p
c
d2 + k2
k2
(z˙− z2
z
z˙).
Since, 
λ = d1x2 + (d2 + k2)s2,
k1x2v2 = (x2 + v2)(d2 + k2)s2,
s2
y2
=
d3
k2
+
pz2
k2
,
y2
v2
=
d4
a
,
s2
v2
=
d3d4
ak2
+
d4 pz2
ak2
,
we have
L˙(x, s, y, v, z) =λ− d1x− x2x
x + v2
x2 + v2
(λ− d1x) + ((d2 + k2)s2) vv2
x2 + v2
x + v
− (d2 + k2)s
− s2
s
(
k1xv
x + v
− (d2 + k2)s
)
+
d2 + k2
k2
(k2s− d3y− pyz)
− d2 + k2
k2
y2
y
(k2s− d3y− pyz) + d3(d2 + k2) + (d2 + k2)pz2ak2
× (ay− d4v)− d3(d2 + k2) + (d2 + k2)pz2ak2
v2
v
(ay− d4v)
+
p
c
d2 + k2
k2
(cyz− bz)− pz2
cz
d2 + k2
k2
(cyz− bz).
On the other hand, we have
λ− d1x = d1x2 + d2 + k2)s2 − d1x,
λ− d1x− (d2 + k2)s2 x + v2k1xv2
(
λ− d1x− k1xvx + v
)
= d1x2(1− xx2 −
x2
x
x + v2
x2 + v2
+
x + v2
x2 + v2
) + (d2 + k2)s2(1− x2x
x + v2
x2 + v2
+
v
v2
x + v2
x + v
),
− s2
s
(
k1xv
x + v
)
+ (d2 + k2)s2 = (d2 + k2)s2(1− s2s
xv
x2v2
x2 + v2
x + v
),
and 
(d2 + k2)d3
k2
y2 − (d2 + k2)s y2y −
(d2 + k2)d3d4
ak2
v
= (d2 + k2)s2
(
1− s
s2
y2
y
− v
v2
)
+
(d2 + k2)
k2
pz2y2
v
v2
− (d2 + k2)
k2
pz2y2,
d4d3(d2 + k2)
ak2
v2 − d3(d2 + k2)k2
v2
v
y = (d2 + k2)s2
(
1− y
y2
v2
v
)
+
(d2 + k2)
k2
pz2y
v2
v
− (d2 + k2)
k2
pz2y2,
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
(d2 + k2)pz2
ak2
(ay− d4v)− (d2 + k2)pz2ak2
v2
v
(ay− d4v) = (d2 + k2)pz2yk2
− (d2 + k2)pz2y2
k2
v
v2
− (d2 + k2)pz2y
k2
v2
v
+
(d2 + k2)pz2y2
k2
,
(d2 + k2)pz2
ak2
(ay− d4v)− (d2 + k2)pz2ak2
v2
v
(ay− d4v)− z2z
p
c
d2 + k2
k2
(xyz− bz)
+
(d2 + k2)
k2
pz2y2
v
v2
− (d2 + k2)
k2
pz2y2 +
(d2 + k2)
k2
pz2y
v2
v
− (d2 + k2)
k2
pz2y2 = 0.
All of these imply
L˙ = − d1v2
x(x2 + v2)
(x− x2)2
− (d2 + k2)s2
(
x(v− v2)2
v2(x + v2)(x + v)
)
+ (d2 + k2)s2
(
5− x2
x
x + v2
x2 + v2
− s2
s
xv
x2v2
x2 + v2
x + v
− sy2
s2y
− yv2
y2v
− x + v
x + v2
)
.
Again, since the arithmetic mean is greater than or equal to the geometric mean, it follows that
5− x2
x
x + v2
x2 + v2
− s2
s
xv
x2v2
x2 + v2
x + v
− sy2
s2y
− yv2
y2v
− x + v
x + v2
≤ 0,
which means that L˙ ≤ 0, and the equality hods when x = x2, s = s2, y = y2, v = v2 and z = z2. By the
LaSalle invariance principle, the endemic point E2 is globally stable.
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